首页> 外国专利> Solid preparation for oral administration comprising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same

Solid preparation for oral administration comprising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same

机译:用于口服的固体制剂,其包含阿魏酸胆碱或其药学上可接受的盐及其制备方法

摘要

PURPOSE: An oral solid formulation containing choline alfoscerate and a method for manufacturing the same are provided to improve stability to moisture, temperature, and light and to enable long-term storage. CONSTITUTION: A pharmaceutical composition comprises: a drug part containing choline alfoscerate or a pharmaceutically acceptable salt thereof; a coating part which is formed at the outside of the drug part and contains a water soluble polymer; and pharmaceutically acceptable additives. The choline alfoscerate is L-alpha-glyceryl phosphoryl choline. An oral solid formulation contains the pharmaceutical composition. The solid formulation is a tablet, a capsule, granules, or a pellet. A method for preparing the pharmaceutical composition comprises: a step of spraying a coating solution containing the water soluble polymers and preparing a drug particle; and a step of adding and mixing the pharmaceutically acceptable additives to the drug particle.
机译:目的:提供了一种包含阿魏酸胆碱的口服固体制剂及其制造方法,以提高其对水分,温度和光的稳定性并能够长期保存。组成:一种药物组合物,其包含:药物部分,其包含胆碱阿魏酸盐或其药学上可接受的盐;和在药物部分的外部形成并包含水溶性聚合物的涂层部分;和药学上可接受的添加剂。磷灰石胆碱是L-α-甘油基磷酰基胆碱。口服固体制剂包含药物组合物。固体制剂是片剂,胶囊剂,颗粒剂或丸剂。一种制备药物组合物的方法,包括:喷涂包含水溶性聚合物的包衣溶液并制备药物颗粒的步骤;将药物可接受的添加剂加入并混合到药物颗粒中的步骤。

著录项

  • 公开/公告号KR101257919B1

    专利类型

  • 公开/公告日2013-04-30

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20110069971

  • 申请日2011-07-14

  • 分类号A61K9/20;A61K9/48;A61K31/661;A61K47/38;

  • 国家 KR

  • 入库时间 2022-08-21 16:25:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号